RecruitingNot Applicable

Validation of the French Version of the Prediction of the Alcohol Withdrawal Severity Scale (PAWSS)

France545 participantsStarted 2024-11-11

Plain-language summary

The goal of this observational study is to validate the French version of the PAWSS scale in a population of patients with Alcohol Use Disorders. Prediction of Alcohol Withdrawal Severity Scale (PAWSS) has an excellent psychometric characteristics and predictive value of complicated alcohol withdrawal. The main question it aims to answer is: Are the psychometric properties of the French version of the PAWSS scale comparable to those of the English version in a population of alcohol use disorders subjects? AUDs participants are included and followed for three days during their hospitalization, They will performed several scales and surveys (DSM-5 AUD criteria, AUDIT, French version of PAWSS and CIWA-AR).

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male or female, aged 18 to 60 years * Subjects with DSM-5 criteria for alcohol use disorders (AUD) * Subjects hospitalized for scheduled withdrawal or patients developing alcohol withdrawal hospitalized for another reason. * Subjects who understand French * Subject affiliated to the French social security system * Subject having given their written consent to the study Exclusion Criteria: * Subjects transferred from other hospitalization services for whom a withdrawal syndrome could have already been treated. * Subjects scheduled for discharge within 48 hours. * Subjects with known uncontrolled epilepsy. * Subjects unable to understand the questionnaire. * Subjects unable to give consent or not volunteering for the study. * Subjects under guardianship or curatorship.

What they're measuring

Psychometric qualities evaluation of French PAWSS

Timeframe: 3 days

Trial details

NCT IDNCT06675539

SponsorEtablissement Public de Santé Barthélemy Durand

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-10

Contact for this trial

Adelaide Aduayi

+33 1 75 02 16 81 adelaide.aduayi@eps-etampes.fr